Workflow
Investment Banking
icon
Search documents
IVVW: BlackRock Jumping Into The S&P 500 Buy-Write Arena, Offers High-Yield
Seeking Alpha· 2025-08-30 06:20
With an investment banking cash and derivatives trading background, Binary Tree Analytics ('BTA') aims to provide transparency and analytics in respect to capital markets instruments and trades. BTA focuses on CEFs, ETFs and Special Situations, and aims to deliver high annualized returns with a low volatility profile. We have been investing for over 20 years after obtaining a Finance major at a top university.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the compan ...
Goldman vs. Evercore: Which Investment Banking Stock Is a Smarter Bet?
ZACKS· 2025-08-29 18:06
Core Insights - Goldman Sachs Group Inc. (GS) and Evercore Inc. (EVR) are prominent U.S. investment banks competing in M&A advisory and dealmaking, with Goldman representing a bulge-bracket bank and Evercore a boutique advisory firm [1] Market Sentiment and M&A Outlook - Market sentiment dipped briefly in early 2025 due to Trump's tariff plans, but M&A activity has regained momentum and is expected to remain strong in the latter half of 2025, driven by better stock valuations, pent-up demand, and corporate consolidation efforts [2] - Regulatory changes under the Trump administration, including looser requirements from the Federal Reserve, are creating favorable conditions for consolidation [2] Goldman Sachs (GS) Analysis - Goldman maintains a leadership position in global M&A, with investment banking revenues increasing by 8% year-over-year in the first half of 2025, supported by a strong deal pipeline and backlog [3] - The company is exiting its non-core consumer banking business to focus on Global Banking and Markets and Asset and Wealth Management (AWM), which is seen as a more stable revenue source [4] - Goldman is exploring acquisitions to expand its AWM footprint, emphasizing the importance of scale in growth [5] Evercore (EVR) Analysis - Evercore generates 94% of its revenues from Investment Banking and Equities, with a compound annual growth rate (CAGR) of 8.6% from 2017 to 2024, continuing to show growth in the first half of 2025 [6] - The company is actively increasing its staff to strengthen its IB business, with 197 senior managing directors as of June 30, 2025, and aims to diversify revenue sources and expand geographically [6] Price Performance and Valuation - Year-to-date, shares of Goldman and Evercore have risen by 31.7% and 17.1%, respectively, compared to the industry growth of 26.8% [7] - Goldman is trading at a 12-month forward P/E of 14.99X, above its five-year median of 10.24X, while Evercore trades at a P/E of 19.64X, above its five-year median of 12.49X [11] - Goldman offers a higher dividend yield of 1.60% compared to Evercore's 1.03%, both exceeding the industry average of 1% [14] Earnings Estimates - The Zacks Consensus Estimate for GS's revenues in 2025 and 2026 suggests year-over-year increases of 6.3% and 6.5%, with earnings expected to rise by 12.6% and 14.9% respectively [17] - For Evercore, the estimates indicate revenue growth of 15.9% and 27.1% for 2025 and 2026, with earnings expected to jump by 31.7% and 50.8% respectively [20] Investment Considerations - Goldman is strategically positioned with a diversified model and a focus on AWM, providing stability and resilience, while Evercore shows strong earnings momentum but carries a high valuation premium and narrower revenue base [23][24] - For long-term investment in the IB sector, Goldman is viewed as the more favorable option due to its balanced approach and solid growth prospects [24]
中金新掌门!70后清华学霸王曙光,27年内部晋升路
业内预计,在王曙光带领下,中金公司将进一步加强在科技企业IPO、跨境并购等核心业务上的优势, 继续引领中国投行业国际化发展。 投行巨头中金公司迎来新总裁! (文章来源:21世纪经济报道) 中金公司过去20多年的总裁多数来自内部提拔,且几乎都拥有深厚投行背景,王曙光正是这一传统的延 续。 8月29日,中金公司正式宣布,任命王曙光为公司总裁,提名执行董事候选人。王曙光党内职务也于8月 升级为中金公司党委副书记。 王曙光的晋升堪称"中金式成长"的典范。51岁的王曙光自1998年从清华大学硕士毕业后加入中金公司, 一待就是27年,从投行部基层岗位一步步崛起:2010年升任董事总经理,2022年执掌投行部并进入管理 委员会,如今全面接管中金公司经营大权。 ...
中金公司迎来新任总裁
Xin Lang Cai Jing· 2025-08-29 15:21
转自:长安街知事 中金公司正式迎来新任总裁。 8月29日,中金公司发布公告表示,聘任王曙光为公司总裁。同时,王曙光还担任了中金公司党委副书 记。 中金公司官网显示,王曙光出生于1974年,1996年获得清华大学理学学士学位及经济学学士学位,1998 年获得清华大学工学硕士学位,同年加入中金公司投行部,2010年1月成为董事总经理。 王曙光先后担任中金公司成长企业投资银行部负责人、中金资本管理部联席负责人、投资银行部负责人 等多个职务,2023年1月任中金公司管理委员会成员。 2024年4月,中金公司发布公告称,因工作变动,吴波不再担任公司总裁、首席财务官及管理委员会成 员职务。此后,中金公司董事长陈亮代行总裁职责,至此次王曙光到任。 ...
IBND: Developed Markets Bonds For A Falling Dollar
Seeking Alpha· 2025-08-28 15:16
A weak dollar in 2025 has been the topic of many discussions, with investors seeing benefits in diversifying into developed and EM markets equities and bonds. We have covered two local currency EM bond funds where we canWith an investment banking cash and derivatives trading background, Binary Tree Analytics ('BTA') aims to provide transparency and analytics in respect to capital markets instruments and trades. BTA focuses on CEFs, ETFs and Special Situations, and aims to deliver high annualized returns wit ...
华兴资本今年上半年全面实现扭亏为盈:三大板块协同发展,深化2.0战略布局
IPO早知道· 2025-08-28 13:39
Core Viewpoint - Huaxing Capital has demonstrated strong performance growth in the first half of 2025, achieving total revenue and net investment income of approximately 460 million RMB, a year-on-year increase of 27%, and successfully turning a profit with a net profit of about 65 million RMB [1] Group 1: Business Performance - The investment banking business of Huaxing Capital generated nearly 70 million RMB in revenue, with transaction volume increasing by 74.6% year-on-year, despite a challenging private equity investment market [3] - The investment management business achieved revenue and net investment income of approximately 240 million RMB, a year-on-year growth of 81%, with operating profit reaching nearly 140 million RMB, a significant increase of 252% [4] - The securities segment reported revenue and net investment income of about 130 million RMB, a year-on-year increase of 25%, with retail brokerage business revenue growing by 110% compared to the previous year [4] Group 2: Strategic Initiatives - Huaxing Capital has initiated the "Huaxing 2.0" strategy, focusing on capturing market opportunities in the digital asset sector, with a dedicated budget of 100 million USD approved for this purpose [7] - The company has successfully positioned itself in the Web3 ecosystem, becoming the sole Asian underwriter for the C1 Fund, a closed-end fund focused on Web3 primary market investments, which successfully listed on the New York Stock Exchange [7][8] - A strategic partnership with YZiLabs has been established to enhance capabilities in digital asset allocation and compliance financial product development, further expanding Huaxing's business boundaries in the Web3 ecosystem [8] Group 3: Market Position and Future Outlook - Huaxing Capital is effectively leveraging its three main business segments—investment management, investment banking, and securities—to achieve high-quality growth, showcasing strong asset liquidity and financial stability with nearly 4.5 billion RMB in cash and high-liquid assets [5] - The company aims to bridge the gap between Web2 and Web3, establishing a comprehensive service capability from investment to asset management, positioning itself as a core hub in the evolving digital economy [8]
Dominari Holdings Files $2 Billion Shelf to Support Strategic Expansion
Prnewswire· 2025-08-28 12:15
NEW YORK, Aug. 28, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) today announced the filing of its shelf registration statement (the "Shelf Registration") on Form S-3 with the U.S. Securities and Exchange Commission (the "SEC"). If the Shelf Registration is declared effective, it will permit the Company to offer and sell, from time to time in one or more offerings, up to $2 Billion worth of shares of common stock, preferred stock, or any combination thereof (the "securities"). Although we have ...
Psyence BioMed to Present at the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025
Globenewswire· 2025-08-28 12:00
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that it will present at the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8–10, 2025. The event, held at the Lotte New York Palace Hotel in New York City and virtually, features more than 550 corporate presentations from lea ...
Time to Jump Into S&P 500 ETFs?
ZACKS· 2025-08-27 17:51
The S&P 500 has gained about 9.93% year to date, but this figure doesn’t fully capture the broader market’s performance in 2025. The year has been marked by volatility, with August reflecting a similar pattern.While the index advanced 3.2% during the month, the index experienced notable swings throughout the month. However, resilient earnings, a supportive macro backdrop, and Fed Chair Powell’s signal of potential rate cuts starting in September paint an optimistic picture for the U.S. economy, easing conce ...
X @Bloomberg
Bloomberg· 2025-08-26 04:44
Nomura plans to start requiring employees in Japan to spend the equivalent of two days a week in the office https://t.co/79jMaD0dll ...